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Abstract
Healthcare organizations strive to provide optimal patient experience by improving care 
quality and enhancing clinical outcomes, while containing associated costs. In the United 
States, the Center for Disease Control (CDC) estimates that more than 1.7 million people 
suffer from an infectious complication annually, representing between 5 and 10% of all hos-
pital admissions and costs ranging between $35B and $88B. Most infectious surface fomites 
originate from air. Consequently, reducing airborne pathogens should be associated with 
reduced surface fomites. This study represents the first comprehensive evaluation of infec-
tious and aerosolized pathogens and their speciation, location and concentration within a 
typical hospital setting. The study provides data regarding the relationship between air-
borne pathogens and air filtration methodologies in the context of the molecular and micro-
bial epidemiology of illness and infections in the clinical setting. The results demonstrated 
that using a transformational air purification system provided comprehensive remediation 
of airborne pathogens and significantly reduced surface-oriented infectious fomites. Overall 
reduction of airborne and surface bacterial and fungal pathogens responsible for illness 
and infections will result in a reduction of associated illnesses and HAI rates and improved 
patient care metrics including stay duration and readmission rates. Improvements in these 
outcome metrics should correlate to risk mitigation and cost avoidance.
Keywords: airborne pathogens, hospital-acquired infections, HAI, patient care, 
bacterial pathogens, fungal pathogens, air filtration, air purification, hospital, molecular 
epidemiology, microbial epidemiology, illness, infection, length of stay, 
readmission rates, clinical outcomes, HEPA, biological particulates, VOC, volatile 
organic compounds, ambient air quality, viable particulates, nonviable particulates
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1. Introduction
In the United States, the Center for Disease Control and Prevention (CDC) estimated that more 
than 1.7 million people suffer from an infectious complication within the hospital environment 
annually, representing between 5 and 10% of all admissions [1]. Approximately 99,000 patients 
afflicted with hospital-acquired infections (HAIs) die each year [2]. The number of estimated 
patients with an HAI exceeds that of any required reportable disease in the United States, and the 
number of deaths attributed to HAIs exceeds many of the top ten leading causes of death reported 
from the US vital statistics [1]. Moreover, the above estimates likely under-represent the true mag-
nitude of the problem due to erroneous reporting and biases inherent to voluntarily reported data.
Apart from the morbidity and mortality associated with HAIs, the estimated healthcare costs 
range between $35B and $88B annually [3]. The most recent Pennsylvania Healthcare Cost 
Containment Counsel (PHC4) Report indicated that hospitals and Medicare spent approxi-
mately $3B and $400 M, respectively, toward statewide care of patients affected by HAIs 
during the reporting year of 2010 [4].
The Centers for Medicare and Medicaid Services (CMS) announced in August 2007 that 
Medicare would no longer cover additional costs associated with many preventable errors, 
including those considered “never events” [5]. The list of events that should never occur in the 
healthcare setting has now been expanded to encompass 29 unique serious reportable events. 
HAIs represent one of the 29 unique “never events” that are no longer reimbursable and may 
even result in further economic penalties [6, 7].
It is estimated that full societal costs associated with HAIs arising in US acute care hospitals 
amount to approximately $96–$147 billion annually [8]. The corresponding per-hospitalization 
incremental cost ranges between $17,070 and $32,176 [8]. Consequently, it can be reason-
ably extrapolated that a three-room surgical suite, performing 1,000 annual surgeries with a 
reported 4% infection rate, would realize a cost avoidance savings of between $171,000 and 
$322,000 per year specific to the surgical suite with only a 1% decline in HAI rates.
Historically, it has been understood that the patient, the healthcare worker, and various 
surface areas collectively constitute the primary repositories of pathogens responsible for 
majority of HAIs [9]. To that end, infection control protocols, in-room sterilization techniques, 
patient preparation, and hand-washing protocols have been implemented in most hospitals 
and have been helpful in reducing overall HAI rates [10]. Moreover, recent literature sug-
gests that a significant proportion of pathogens responsible for HAIs are airborne [11]. The 
Aire~HCX™ (LifeAire Systems, Allentown, Pennsylvania) [12] was specifically designed to 
comprehensively address these airborne pathogens (AP) as they are inherently generated 
during routine clinical operations. In environments where Aire~HCX™ is employed, infec-
tious APs are remediated in both the supply and return air before entering the clinical space.
The LifeAire Systems’ advanced air purification technology (LAS-APS) exceeds the limitations 
associated with commonly utilized mechanisms of air filtration [13]. Many in-room steriliza-
tion technologies require that the clinical space be vacated before use, leading to temporary 
loss of functional space. The in-room approaches also provide a “static” clean at the exact time 
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of use [14, 15]. Reentry of patients and healthcare workers and the initiation of clinical pro-
cesses inherently serve as a source of rapid re-establishment of pathogen populations [16–18]. 
Unlike the “static” clean model of many of the in-room units, the LAS-APS provides real-time 
remediation of APs as they are generated during clinical operation. In addition, unlike the 
“capture” model of the commonly used HEPA filters, the LAS-APS uses a “kill” model and is 
mathematically and genomically modeled to destroy the DNA and RNA of all bacteria and 
viruses such that they are rendered noninfectious. HEPA filtration is based upon the capture 
of viable biological particulates, allowing the spores to grow and proliferate above the space 
being protected. Air flowing over the spores can disturb and dislodge them such that they 
enter the clinical space [19]. The “kill” mechanisms incorporated into the LifeAire Systems’ 
technology eliminate these possibilities.
LifeAire Systems’ Aire~HCX™ purification unit is installed within the healthcare facility’s 
heating ventilation and air conditioning (HVAC) ductwork. The system is designed to deliver 
ultrapure, contaminant-free air to any clinical environment. Based on over a decade of research, 
development, and testing, the Aire~HCX™ system has been tested and proven to deliver air 
that is 99.99% free of any contaminants, with an associated air purity guarantee [12, 13]. In 
essence, the LAS-APS was designed to remove all airborne biological pathogens and thus 
enhance patient safety of the intended healthcare environment by reducing HAI incidence rates, 
as exemplified by the current collaborative effort between LifeAire and St. Luke’s University 
Health Network (SLUHN). With 69–80% of the pathogens responsible for HAIs being airborne 
at some point, aggressive remediation of all airborne pathogens will provide for improved 
patient care and outcomes while reducing the financial burden associated with HAIs.
2. Genesis of LAS-APS air filtration paradigm
With more than a decade of clinical research into the critical role of ambient air quality, the 
principal investigator (KCW) designed, tested, and patented their transformational air purifi-
cation technology [12, 13]. This work revealed that one of the key factors impacting successful 
clinical outcomes was that of the ambient air. Current standards and guidelines as stated 
are inadequate to provide ambient air optimal for the clinical and patient setting. The clini-
cal environment is impacted by events both external and internal to the space in question. 
The research highlighted the significant contribution made by patients, healthcare workers, 
and various clinical processes [20]. External environmental events, even those outside of the 
immediate proximity of a clinical space, were also found to greatly impact positive outcomes 
[21–28]. By removing airborne chemical and biological pathogens to below-detection levels, 
the LAS-APS provides unprecedented control over air quality and significant positive impact 
on clinical outcomes [25–28].
The LAS-APS provides extremely high levels of filtration as it was designed to kill the anthrax 
spore (e.g., the most difficult biological pathogen to kill) [29]. The technology used in LAS-APS-
patented technology has been tested by the National Homeland Security Research Center and 
by other third parties. Results indicate that the system renders a broad spectrum of pathogens 
inert and that it virtually eliminates threatening biological pathogens and volatile organic 
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chemicals from the air—to a level of effectiveness not previously commercially available. 
Because of its effectiveness toward Bacillus anthracis, the LifeAire Systems is able to reme-
diate airborne pathogens such as Clostridium difficile, Aspergillus, Streptococcus, Pseudomonas, 
Staphylococcus (including methicillin-resistant variety), smallpox virus, Mycobacterium tuber-
culosis, influenza virus, etc., each representing a consistent threat to both the hospital environ-
ment and rates of HAIs [unpublished data].
3. Materials and methods
The design of the current study includes three zones within two medical surgical floors of 
a SLUHN Allentown hospital campus. The three geographic zones (Figures 1–3) include 
a control floor with air handling unit (CF-AHU) HEPA-filtration remediation, a zone with 
mixed AHU-HEPA and LifeAire remediation (MIXED) with recirculated air, and a zone with 
comprehensive LifeAire Systems Air Remediation (LSAR). Within each of these zones, two 
occupied and active patient rooms were selected for air quality testing. Each of the two rooms 
was comprehensively evaluated per zone. The patient rooms were chosen such that the effects 
of elevators/entrances/exits as well as zone barriers would be minimized. Rooms were further 
chosen to optimize direct comparisons of resulting data. Table 1 illustrates the zones and 
rooms evaluated during the study.
During each testing event, one of the two rooms listed were chosen for the complete suite of 
particulate, biological, and volatile organic compound (VOC) testing. For this study, the two 
rooms in each zone were considered equivalent. For each specific testing event, room preference 
was for patient occupancy, followed by consistency within each room between measurements.
Figure 1. Schematic representing the CF-AHU on the control floor.
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Each of the rooms underwent comprehensive evaluation for airborne and surface viable bac-
terial, fungal, and VOC loads. Three commonly touched patient surfaces and two commonly 
touched clinical surfaces were evaluated per testing assay (Tables 2 and 3). In addition, the 
final diffuser providing supply air to the patient room and the return vents were swabbed for 
viable bacteria and fungi (Table 4).
Figure 2. Schematic representing LSAR and MIXED zones, respectively.
Figure 3. Schematic representation of HVAC layout of the MIXED and LSAR zones.
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3.1. Testing assay: viable bacteria by air
Air testing was completed using the third-party laboratories, EMSL, and Galson Laboratories 
under their proprietary method MICRO-SOP-132 [30, 31]. Following the standard operating pro-
cedures (SOPs) provided by the third-party laboratories and using a Viable Andersen Cascade 
Impactor and calibrated pump, samples were gathered for 5 minutes at 28 liters per minute onto 
a soy agar plate. The five most concentrated species were then identified and quantified.
3.2. Testing assay: viable bacteria by swab
Surface testing was conducted following all SOPs of the third-party laboratories. Using 
a sterile swab, an area measuring 2-by-2 inch was sampled in each location with a smooth 
back-and-forth motion while rolling the swab for 10 seconds. The swab was then capped and 
sent to the third-party laboratory for testing under method MICRO-SOP-132 [30]. The most 
prominent five types of bacteria were identified and quantified.
Bedside table (directly in front of patient)
IV support pole/IV support pole
Patient remote control—number buttons
Table 2. Patient surface sampling sites.
Zone HVAC design
CF-AHU AHU-HEPA remediation
MIXED AHU-HEPA and LifeAire systems remediation
LSAR LifeAire systems air remediation
Table 1. HVAC design by study zone.
IV control faceplate
Pressure cuff bulb
Table 3. Clinical surface sampling sites.
HVAC room diffuser
HVAC room return
Table 4. HVAC surface sampling sites.
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3.3. Testing assay: viable fungi by air
Air testing was completed using a third-party laboratory under their proprietary method 
MICRO-SOP-202 [30]. Following the SOPs provided by the third-party laboratories and using 
a Viable Andersen Cascade Impactor and calibrated pump, samples were gathered for 5 min-
utes at 28 liters per minute onto a MEA agar plate. The five most concentrated species were 
identified and quantified.
3.4. Testing assay: viable fungi by swab
Surface testing was conducted following applicable SOPs of the third-party laboratories. 
Using a sterile swab, an area measuring 2-by-2 inches was sampled in each location with 
a smooth back-and-forth motion while rolling the swab for 10 seconds. The swab was then 
capped and sent to the third-party laboratory for testing under method MICRO-SOP-202 [30]. 
The five most prominent species of viable fungi were identified and quantified.
3.5. Testing assay: volatile organic compounds (VOC) testing
The measured VOC load of each room was determined using the methodology described in 
EPA TO-15 [32]. Using an evacuated container, air was captured for 15 minutes. The TO-15 
assay determines VOCs in air collected using specially prepared stainless steel canisters and 
subsequently analyzed by gas chromatography/mass spectrometry (GC/MS). Due to the live 
hospital setting and available locations to place the testing cylinder, longer sampling times 
were considered but not employed due to the risk of sample tampering by unmonitored 
patients, visitors, and clinical staff.
3.6. Testing assay: nonviable particulate testing
Particulate testing was conducted using a modified NIOSH 0500 method [33]. Sampling was 
conducted for 5 minutes at each testing site. The environmental testing was completed each 
month with sampling beginning in the morning and progressing through early afternoon. 
Clinical, housekeeping, operational staff and patients were blinded to both the study and zone 
locations to minimize any biases associated with behaviors or perceptions. Cleaning SOPs, 
patient care operations, patient appointment schedules, visitation, patient dining, and all oper-
ations of the floor remained unchanged. Sampling occurred during normal visitations, staff 
consultations, and meals to allow data acquisition and flow to simulate full hospital operations.
4. Results
The overall study results are presented in Figure 4 and in Tables 5–7. All data were provided 
by independent third-party laboratories after sampling the air and designated surfaces in each 
patient room associated with the specific study zone, as outlined in the methodology section. 
A comprehensive environmental assessment of viable bacterial, fungal, and VOC pathogens 
was conducted each month and repeated a total of 4 times between March and July of 2018.
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Figure 4. Results for viable airborne and surface bacteria and fungi and VOC load in each zone (CF-AHU, MIXED, and 
LSAR). Legend: AHU, air handling unit; VFBA, viable fungi by air (CFU/m3); VFBS, viable fungi by swab (CFU/in2); 
VBBA, viable bacteria by air (CFU/m3); VBBS, viable bacteria by swab (CFU/in2); VOCs, volatile organic compounds 
(ppb); PT, particulates (mg/m3).
Zone VFBA VFBS VBBA VBBS
CF-AHU Aspergillus Aspergillus Micrococcus luteus Micrococcus lylae
Cladosporium Cladosporium 
(remote, return)
Staphylococcus spp.: capitis, 
epidermidis, haemolyticus, 
saprophyticus
Staphylococcus spp.: capitis, 
haemolyticus (remote, return), 
hominis, saprophyticus (return)
Gram-negative rod Gram-negative rod (return)
Bacillus spp.: clausii, licheniformis Gram-positive cocci (remote, 
return)
Dermabacter hominis
Kocuria palustris
MIXED Yeast Rhodotorula 
(return)
Staphylococcus haemolyticus Nil
Bacillus licheniformis
Dietzia cinnamea
Streptococcus anginosus
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Zone VFBA VFBS VBBA VBBS
LSAR Nil Nil Nil Staphylococcus spp.: capitis 
(patient remote), epidermidis 
(faceplate)
Corynebacterium (patient 
remote)
Table 5. Identification of viable bacteria and fungi by air and on surface within the three study zones (CF-AHU, MIXED, 
and LSAR).
Pathogen Association with patient illness Location within clinical 
space
Aspergillus Associated with pulmonary infections, infections to skin lesions Circulating air in patient 
room
Patient remote
HVAC Return
Cladosporium Associated with infections to skin, sinuses, and lungs; significant 
allergens impacting asthmatics and patients with respiratory 
diseases; spores produce toxic VOCs
Circulating air in patient 
room
Patient Remote
HVAC Return
Staphylococcus 
saprophyticus
Associated with urinary tract infections Circulating air
in patient room
Return
Staphylococcus 
epidermidis
Skin flora and low association with HAIs Circulating air in patient 
room
Staphylococcus capitis Natural skin flora often associated with infections caused by 
catheters and aortic valves
Circulating air in patient 
room
Patient Remote
HVAC Return
Micrococcus luteus Source is typically patient-oriented, mouth, mucosae, oropharynx, 
and upper respiratory tract, often associated with ill patients
Circulating air in patient 
room
Staphylococcus 
haemolyticus
Antibiotic resistant and associated with skin flora Circulating air in patient 
room
Patient Remote
HVAC Return
Bacillus clausii Associated with respiratory infections and GI disorders, produces 
antimicrobial substances active against Staphylococcus aureus, C. 
difficile, and Enterococcus faecium
Circulating air in patient 
room
Bacillus licheniformis Associated with soil and bird plumage Circulating air in patient 
room
Dermabacter hominis Associated with wound infections, abscesses, and positive blood 
cultures
Circulating air in patient 
room
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Pathogen Association with patient illness Location within clinical 
space
Kocuria palustris Pathogen responsible for UTIs Circulating air in patient 
room
Gram-positive cocci Staphylococcus aureus and Streptococcus pyogenes are two of 
the most common causes of hospital-acquired pneumonia, 
septicemia, folliculitis, and surgical site infections
Patient Remote
HVAC Return
Gram-negative rods Associated with E. coli, Salmonella, Shigella, Pseudomonas, severe 
GI illness
Circulating air in patient 
room
HVAC Return
Micrococcus lylae Associated with skin flora, opportunistic pathogen in 
immunocompromised patients
HVAC Return
Staphylococcus hominis Associated with infections in immunocompromised patients HVAC Return
Table 6. Pathogen characteristics of zone CF-AHU (the control zone).
Pathogen Association with patient illness Location within clinical 
space
Yeast Associated with pulmonary infections and skin lesion 
infections
Circulating air in 
patient room
Rhodotorula Common clinical contaminant associated with soil and water HVAC Return
Staphylococcus haemolyticus Antibiotic resistant and associated with skin flora Circulating air in 
patient room
Bacillus licheniformis Associated with soil and bird plumage Circulating air in 
patient room
Dietzia cinnamea Associated with catheter and orthopedic prosthesis-
associated infections in immunocompromised patients
Circulating air in 
patient room
Streptococcus anginosus Common cause of abscesses, abdominal and thoracic 
infections, endocarditis, and bacteremia
Circulating air in 
patient room
Table 7. Pathogen characteristics of MIXED zone-partial remediation (CF-AHU and 35% LSAR).
Pathogen Association with patient illness Location within clinical 
space
Staphylococcus epidermidis Skin flora and low association with HAIs IV control faceplate
Corynebacterium Normal skin flora, low association with infections, 
prosthetic devices
Patient Remote
Staphylococcus capitis Natural skin flora often associated with infections caused 
by catheters and aortic valves
Patient Remote
Table 8. Pathogen characteristics of LSAR zone patient rooms.
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There were 3100 ppb VOCs and <8.3 mg/cubic meter of nonviable particulates in CF-AHU 
Zone (Table 6).
There were no viable bacteria by swab, 2350 ppb VOCs, and <8.3 mg/cubic meter of nonviable 
particulates in the MIXED Zone (Table 7).
Finally, there were no viable bacteria by air, no viable bacteria by swab, no viable fungi by air, 
1300 ppb VOCs, and < 8.3 mg/cubic meter of nonviable particulates in LSAR Zone (Table 8). 
The reduction in VOCs is due to the remediation of viable fungal spores and their concomitant 
production of fungal VOCs. As there was a HEPA filter in place on the serving air handling 
unit, all air was HEPA-filtered. This was confirmed by the nonviable particulate assessment 
of <8.3 mg/cubic meter in all study zones.
5. Discussion
Often neglected, indoor air quality is an important component of ensuring healthy and 
safe environment across various healthcare facilities [34]. It is well established that there 
exists “strong and sufficient evidence” of the association between ventilation, air move-
ments in buildings, and the transmission of bacterial, fungal, and viral infectious diseases 
[35]. Consequently, the need for high efficiency/reliable air filtration becomes a necessity, 
especially in critical environments such as acute care wards, critical care units, isolation 
units, and operating rooms [36–38]. The current project highlights the importance of an 
integrated system, such as the LAS-APS, in the modern healthcare environment. The sub-
sequent discussion will synthesize our study’s results in the context of acute care hospital 
setting.
Perhaps most importantly, we noted a substantial decrease in air contaminants across all mea-
surement categories. As the degree of air remediation increased from CF-AHU Zone or the con-
trol floor to comprehensive coverage in the patient rooms in LSAR Zone, a significant decrease 
in airborne bacterial, fungal, and VOC load was observed. The decrease in both bacterial and 
fungal loads within the air was concomitant with a significant decrease observed on commonly 
touched clinical and patient surfaces. Within the control zone, many of the pathogens identified 
in air samples from patient rooms were also found on commonly touched patient surfaces and 
on the return vents of the room. This data provides a significant contribution to our under-
standing of the airflow and path of aerosolized pathogens within the typical clinical space.
Previously published data show a strong relationship between the presence of airborne fun-
gal spores and air quality in the hospital setting [39]. As part of the current study, viable fungi 
species of Aspergillus and Cladosporium were speciated and quantitated within the control 
zone patient rooms. Our results demonstrate a substantial decrease in fungal spore detection 
rates when using LAS-APS technology, as compared to the other approaches.
The presence of bacteria, both in the air and on various surfaces, has been shown to be 
deleterious to healthcare outcomes [40, 41]. In addition to the fungal species, viable bacterial 
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species were also identified within the patient rooms of the control zone. Staphylococcus sap-
rophyticus, Staphylococcus epidermidis, Staphylococcus capitis, Micrococcus luteus, Staphylococcus 
haemolyticus, Bacillus clausii, Bacillus licheniformis, Dermabacter hominis, Kocuria palustris, 
Gram-positive cocci, Gram-negative rods, Micrococcus lylae, and Staphylococcus hominis were 
found in both the recirculating air of the patient room and on the patient remote and HVAC 
return. Many of the aerosolized pathogens found within the recirculating air were found 
on the HVAC return vents. Presence of these pathogens on the return vents confirms their 
aerosolized nature and threat to the clinical spaces also served by the recirculated air. With 
the exception of Bacillus licheniformis, each of these pathogens is associated with patient ill-
ness and infections. The sources of the above airborne pathogens are most likely the patients, 
visitors, and healthcare workers [42, 43].
It is also important to note that patient rooms in the MIXED Zone received approximately 
35% of their recirculated air from the rooms from the LSAR Zone and thus benefited from 
the installed LAS-APS filtration capacity. The zone also served as an “internal control” as 
it was located on same the floor as LSAR Zone. Viable yeast was found in the circulating 
air of the patient rooms in LSAR Zone, and viable Rhodotorula was found on the HVAC 
return vent. Although at a significantly reduced level from that observed in CF-AHU 
Zone, viable bacteria were identified within the air of the patient rooms of MIXED Zone. 
Staphylococcus haemolyticus, Dietzia cinnamea, and Streptococcus anginosus, each a potential 
source of patient illness and infection, were identified in the patient rooms of MIXED 
Zone. Bacillus licheniformis was also identified but is not associated as a source of patient 
illness or infection. Interestingly, there were no viable bacteria found on the surfaces 
swabbed in MIXED Zone. VOCs were reduced over that assessed in CF-AHU Zone. The 
reduction of viable fungi in MIXED Zone corresponded to the simultaneous reduction in 
fungal VOC sources.
The patient rooms in LSAR Zone received all of their supply and recirculated air from the 
LAS-APS installation. There were no viable fungi by air or swab detected in the patient 
rooms in LSAR Zone. Likewise, there were no viable bacteria by air detected in the patient 
rooms in LSAR Zone. Low levels of Staphylococcus epidermidis were found on the IV control 
faceplate, and Corynebacterium and Staphylococcus capitis were found on the patient remote. 
Because no viable bacteria were identified within the air of the patient rooms in LSAR 
Zone, the surface bacteria identified on the patient remote and IV control faceplate were 
most likely due to direct surface-to-surface contact. The lowest levels of VOCs were found 
in the patient rooms of LSAR Zone as these rooms demonstrated no viable fungi in the 
circulating air.
The vast majority of infectious surface fomites originate from the air and may be directed 
onto surfaces by air flow generated by in-room fans and air conditioning systems [44–46]. 
Consequently, a reduction in airborne bacterial and fungal pathogens should be associated 
with a reduction in surface fomites [44, 47]. Overall reduction of airborne and surface bacte-
rial and fungal pathogens responsible for patient illness and infections should result in a 
reduction of associated illnesses, HAI rates, and improved metrics of patient care inclusive 
of, but not limited to, length of stay and readmission rates. Improvements in these outcome 
metrics should, by association, correlate to risk mitigation and cost avoidance.
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It is important to note that the current, preliminary study represents the first comprehen-
sive evaluation of infectious and aerosolized pathogens and their speciation, location, and 
concentration within a typical hospital setting. The study provides important data regarding 
the complex relationship between airborne pathogens and air filtration methodologies in the 
context of the molecular and microbial epidemiology of illness and infections in the clinical 
setting. A greater understanding of the role of airborne pathogens in illness in the clinical 
setting will help facilitate the identification of proper and more optimal levels of remediation.
6. Summary
In the modern healthcare environment, organizations strive to provide optimal patient expe-
rience by improving the quality of patient care, enhancing clinical outcomes, while at the 
same time containing associated costs. Rarely is there an opportunity to utilize technology 
that positively impacts quality and cost of hospital care without a detrimental “trade off” or 
major changes in existing behaviors or protocols. We hypothesized that LAS-APS implemen-
tation within the SLUHN facility will lead to notable enhancements in air quality across areas 
serviced by this air filtration/purification system. The current study clearly demonstrates a 
significant reduction across all forms of air contamination following the installation of LAS-
APS. These results represent an important milestone for further research in this critical and 
often neglected area of healthcare facility operations and maintenance.
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